About: Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 1995 (uk) article scientifique publié en 1995 (fr) im April 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 1995 (ast) scientific article published on 01 April 1995 (en)
publication date	wds:Q72112446-10E24A28-A36F-4900-9890-DA63F12F599E
publication date	1995-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72112446-6E99C375-1BB4-498A-A15F-9E68FC02DC40
language of work or name	English
author name string	wds:Q72112446-8CFA3602-2DBB-4E86-BA15-8553F0F24014 wds:Q72112446-B1C7AB75-E4F9-4FF6-AAF8-FD3B151521A0 wds:Q72112446-B303B225-EFBE-4FCF-AEA6-7DEB363A78E8 wds:Q72112446-C339C413-E8FA-4417-B03C-D23FE239B01F wds:Q72112446-D2DFB112-616E-4BD9-8462-C256DDDAD406 wds:Q72112446-E5C9C482-9377-4F4B-BF41-CB27E14D9CFF
author name string	J Guitart T M Kuzel K B Gordon J VonRoenn L R Eramo A Tajuddin
rdfs:label	Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy (en) Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy (nl)
skos:prefLabel	Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy (en) Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy (nl)
name	Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy (en) Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy (nl)
title	wds:Q72112446-7756FE80-1697-42AB-940E-D641EDFB4CF2
title	Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy (en)
page(s)	wds:Q72112446-4B5975AA-3C4B-43D0-A798-E35F5C25C06B
page(s)	2169-2173
instance of	wds:Q72112446-2EA06BA3-8B02-4FCA-9C98-F32DD9BA9C3A
instance of	scholarly article
main subject	wds:Q72112446-676EFDCF-E8E6-47B0-9913-82D7D2E92DB6 wds:Q72112446-8475EF9A-6644-4906-8CE0-049B0A307AF3
main subject	wd:Q18936 chemotherapy-induced acral erythema
PubMed ID	wds:Q72112446-1F42EDFA-F9FF-4EB1-ADBC-92112FB85CCF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7697608
PubMed ID	7697608
published in	wds:Q72112446-B546148C-C2E6-4D29-80CF-5FDAADF896CF
published in	Cancer
issue	wds:Q72112446-199FE48A-E648-4844-A0B2-B53B437CD83F
volume	wds:Q72112446-D62830FE-1FD2-4834-82CF-EF49F155D25C
issue	8
volume	75
DOI	wds:Q72112446-6D85C0E0-B040-4403-9C5A-BA55ADE2B125
DOI	http://dx.doi.org/10.1002/1097-0142(19950415)75:8%3C2169::AID-CNCR2820750822%3E3.0.CO;2-H
DOI	10.1002/1097-0142(19950415)75:8<2169::AID-CNCR2820750822>3.0.CO;2-H
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72112446
is cites work of	Liposomally targeted cytotoxic drugs for the treatment of cancer Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies Rate of biodistribution of STEALTH liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin Mucocutaneous reactions to chemotherapy Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of Doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity. Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment Polymer-coated echogenic lipid nanoparticles with dual release triggers. Crucial functionalizations of carbon nanotubes for improved drug delivery: a valuable option? Promising approaches in acute leukemia Chemotherapy of AIDS--related Kaposi's sarcoma Topical henna for capecitabine induced hand-foot syndrome Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma Nonviral delivery for genomic therapy of cancer Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy Myths concerning the use of cationic liposomes in vivo Reversible masking using low-molecular-weight neutral lipids to achieve optimal-targeted delivery Pyridoxine for prevention of hand-foot syndrome caused by chemotherapy: a systematic review Prophylactic pyridoxine was not able to reduce the incidence of capecitabine-induced hand-foot syndrome: A meta-analysis Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group Liposomal drug delivery Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases Hand-foot syndrome with docetaxel: a five-case series Vascular endothelial growth factor (VEGF) antibody significantly increases the risk of hand-foot skin reaction to multikinase inhibitors (MKIs): A systematic literature review and meta-analysis. Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report Concurrent hand-foot skin reaction and hair depigmentation with sunitinib: report of a case and literature review of kinase inhibitors and blocking antibodies Liposome technology and the development of Myocet™ (liposomal doxorubicin citrate) Nanotechnology and drug delivery: an update in oncology Acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Biology and management Anti-EGFR antibody conjugated organic-inorganic hybrid lipid nanovesicles selectively target tumor cells Optimization of Non-Viral Gene Therapeutics Using Bilamellar Invaginated Vesicles. Small Peptide-Doxorubicin Co-Assembly for Synergistic Cancer Therapy Dermatologic toxicity to sorafenib Anthracyclines in haematology: pharmacokinetics and clinical studies The Role of Carotenoids in Human Skin
is cites work of	wds:Q42177203-681C38BF-9B86-4F61-AE12-5CF9720BBFA1 wds:Q41175512-B223C33A-9A71-4062-AA4D-6783841D6EFE wds:Q52654231-37352624-4B83-41FD-91FA-3B5346A5489B wds:Q30366990-DDA70AB1-F89A-4ABA-ACFB-630813D6283E wds:Q33929477-42D2D0CE-60C3-4F43-AC32-CEDAEEB2F217 wds:Q34973732-CA35BEFB-21B5-4575-8B0D-DFA5D0FA77DE wds:Q37368022-C8ABDE68-5F54-43AD-B964-60368AF3FEB7 wds:Q38981073-E90DF82A-CAF6-4468-AA3A-D72DD4D2319A wds:Q41444558-60BFA32D-655A-4871-825C-306BACC63BD5

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 173 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software